Peg12 Inhibitors
Peg12 inhibitors encompass a range of chemical compounds that intercept specific signaling pathways and biological processes to diminish the functional activity of the Peg12 protein. Rapamycin, for example, is a potent mTOR inhibitor that obstructs the mTOR signaling pathway, essential for protein translation including that of Peg12, thereby directly reducing Peg12 protein synthesis. Similarly, both Wortmannin and LY294002 thwart the PI3K/Akt/mTOR cascade, curtailing the upstream signaling that leads to Peg12 protein synthesis. Inhibition of Akt by Triciribine also diminishes mTOR pathway activity, which is crucial for Peg12 translation. Furthermore, cell-cycle modulation by Roscovitine through its cyclin-dependent kinase inhibitory action has the potential to indirectly alter Peg12 protein levels by changing the cellular milieu necessary for its optimal expression.
Continuing with the theme of pathway-specific inhibition, PD98059 and U0126 target the MAPK/ERK pathway, another conduit that can influence Peg12 levels through its role in regulating protein synthesis. The inhibition of autophagy by Spautin-1 can disrupt cellular homeostasis, leading to a differential expression of proteins, including a decrease in Peg12. SB203580's interference with the p38 MAPK pathway, Dasatinib's broad-spectrum Src kinase inhibition, Lapatinib's blockade of EGFR/HER2 signaling, and Sunitinib's targeting of various receptor tyrosine kinases, all contribute to the alteration of Peg12 activity and levels by manipulating the signaling networks that regulate the protein's function and expression. Each inhibitor, by targeting distinct molecules and pathways, ensures a comprehensive strategy to attenuate Peg12 activity, leveraging the interconnectedness of cellular signaling to achieve a cumulative effect.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that impedes the mTOR pathway, which is crucial for the translation of many proteins. As Peg12 translation requires mTOR signaling, rapamycin effectively reduces Peg12 protein levels by inhibiting this pathway. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A PI3K inhibitor that suppresses the PI3K/Akt/mTOR signaling pathway. By inhibiting this pathway, wortmannin indirectly decreases the translation and activity of Peg12 by reducing upstream signaling. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Another PI3K inhibitor, similar to wortmannin, LY294002 disrupts the PI3K/Akt/mTOR cascade, leading to a decrease in Peg12 protein synthesis due to attenuated signaling. | ||||||
Triciribine | 35943-35-2 | sc-200661 sc-200661A | 1 mg 5 mg | $104.00 $141.00 | 14 | |
An Akt inhibitor that prevents the activation of Akt, a kinase downstream of PI3K, thereby reducing the activity of mTOR and subsequently diminishing Peg12 protein synthesis. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $94.00 $265.00 | 42 | |
A cyclin-dependent kinase inhibitor (CDKi) that affects cell cycle progression. By modifying the cell cycle, roscovitine can indirectly influence the synthesis of Peg12 by altering the cellular environment necessary for its expression. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
A MEK inhibitor that impairs the MAPK/ERK pathway, a pathway that can regulate protein synthesis. Inhibition of this pathway can lead to reduced Peg12 levels as ERK is indirectly involved in the control of protein translation. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
Similar to PD98059, U0126 is a selective inhibitor of MEK, which acts upstream of ERK in the MAPK pathway. By inhibiting MEK, U0126 decreases ERK activity, which may in turn reduce Peg12 protein levels. | ||||||
Spautin-1 | 1262888-28-7 | sc-507306 | 10 mg | $168.00 | ||
A specific inhibitor of autophagy by targeting ubiquitin-specific peptidases, leading tothe degradation of autophagy-related proteins. Since autophagy can regulate the turnover of cellular proteins, inhibiting this process with Spautin-1 can result in the accumulation of certain proteins while decreasing the levels of others, such as Peg12, by disrupting normal cellular homeostasis. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor that disrupts the p38 MAPK signaling pathway often involved in stress responses and inflammation. By inhibiting p38 MAPK, SB203580 can indirectly interfere with the signaling mechanisms that may regulate Peg12 expression. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
A Src family kinase inhibitor that can affect multiple signaling pathways, including those that might be involved in the regulation of Peg12. By inhibiting Src kinases, Dasatinib may alter the activity of pathways that modulate Peg12 levels. | ||||||